Received Jan 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | KA532 | — |
MI Hiberix Administration of only the diluent portion; MI Hiberix Administration of only the diluent portion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 4-month-old female patient who received Hib (Hiberix) (batch number KA532, expiry date 19-OCT-2026) for prophylaxis. On 19-JAN-2026, the patient received Hiberix. On 19-JAN-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate dose of vaccine administered (Verbatim: MI Hiberix Administration of only the diluent portion) and inappropriate preparation of medication (Verbatim: MI Hiberix Administration of only the diluent portion). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 20-JAN-2026 A nurse mentioned that an employee administered only the liquid portion of Hiberix to a patient. The nurse wants to know if it was possible to use a different saline solution to reconstitute the Hiberix powder in order to not waste the vaccine. The lot number provided corresponds to the vial containing the lyophilized component.